The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?

CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY(2022)

引用 0|浏览1
暂无评分
摘要
Purpose of review The 1 mg overnight dexamethasone suppression test (ONDST) with a cutoff cortisol value of 1.8 mcg/dl (50 nmol/l) is routinely used for the assessment of incidental, benign adrenal nodules. Patients with an abnormal test are diagnosed with mild autonomous cortisol secretion (MACS). This timely commentary reviews the origins of the ONDST, its relationship to the diagnoses of MACS, and whether this is clinically relevant for clinical care. Recent findings Millions of incidental adrenal nodules are found on CT scans annually. Several papers in the last three years discuss and advocate for the diagnose of MACS via the ONDST. An ONDST cutoff of 1.8 mcg/dl (50 nmol/l) in patients with no clinical features of Cushing's syndrome will produce false positive results and a diagnosis of MACS that could result in unnecessary adrenalectomy.
更多
查看译文
关键词
adrenal nodule, adrenalectomy, cortisol, Cushing's disease, Cushing's syndrome, dexamethasone, mild autonomous cortisol secretion, overnight dexamethasone suppression test
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要